Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Site selectivity of daunomycin

C J Roche1, J A Thomson, D M Crothers

  • 1Department of Chemistry, Yale University, New Haven, Connecticut 06511.

Biochemistry
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate change and the integrity of science.

Science (New York, N.Y.)·2010
Same author

RNA folding pathways.

Current protocols in nucleic acid chemistry·2008
Same author

Polyethylene glycol solution as an oral contrast agent for MRI of the small bowel in a patient population.

Clinical radiology·2006
Same author

Spontaneous ureterocolic fistula secondary to calculous pyohydroureteronephrosis.

The British journal of radiology·2005
Same author

Comparison of analyses of DNA curvature.

Journal of biomolecular structure & dynamics·2003
Same author

SAPHO syndrome presenting as septic arthritis in the hip.

Irish medical journal·2003

The antitumor drug daunomycin binds effectively to specific DNA sequences, with affinity comparable to or better than calf thymus DNA. Its binding is influenced by flanking adenine tracts and helix stability.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Daunomycin is an antitumor drug with known DNA-binding properties.
  • Understanding daunomycin's interaction with specific DNA sequences is crucial for optimizing its therapeutic potential.
  • Previous studies indicate daunomycin binds poorly to poly(dA).poly(dT) sequences.

Purpose of the Study:

  • To reexamine the binding properties of daunomycin using precisely designed double-helical oligonucleotides.
  • To identify and characterize preferred daunomycin binding sites within a six base pair core sequence.
  • To investigate the influence of flanking adenine tracts and helix stability on daunomycin binding affinity.

Main Methods:

  • Synthesis of 16 base pair oligonucleotides with defined core sequences and flanking adenine tracts.

Related Experiment Videos

  • Utilized fluorometric, absorption, calorimetric, and stopped-flow techniques to study drug-DNA interactions.
  • Compared binding affinities to various synthetic sequences and calf thymus DNA.

    • Main Results:

    • Daunomycin affinity for oligonucleotides with preferred sites was comparable to or enhanced relative to calf thymus DNA (association constants: 1.0 x 10(8) to 3.0 x 10(7) M-1).
    • The CGTACG sequence showed the strongest core binding, though only twofold greater than other core sequences.
    • Appreciable binding to flanking adenine tracts was observed, and hairpin structures significantly reduced binding affinity.

    Conclusions:

    • Specific DNA sequences enhance or maintain daunomycin binding affinity.
    • Flanking adenine tracts contribute to binding, indicating a complex interaction model.
    • Kinetic and thermodynamic data suggest the presence of both strong and weaker binding sites, influenced by DNA structure and stability.